EDIM-TKTL1 blood test: A noninvasive method to detect upregulated glucose metabolism in patients with malignancies

Future Oncology

Volumn 8, Issue 10, 2012, Pages 1349-1359

  Feyen, Oliver ^a   Coy, Johannes F ^a   Prasad, Vikas ^b,c   Schierl, Ralf ^a   Saenger, Joerg ^d   Baum, Richard P ^b  

^a Darmstadt and Tavargenix GmbH   (Germany)

^b Zentralklinik Bad Berka   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Institute of Pathology   (Germany)

Author keywords

blood test; diagnostic; EDIM; FDG PET; glucose metabolism; malignancy; oncology; TKTL1; transketolase like 1; upregulation

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TRANSKETOLASE; TRANSKETOLASE LIKE 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BLOOD ANALYSIS; BREAST CARCINOMA; CANCER OF UNKNOWN PRIMARY SITE; COLORECTAL CARCINOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORRELATION ANALYSIS; EPITOPE DETECTION IN MONOCYTE TEST; ESOPHAGUS CANCER; FEMALE; GERM CELL TUMOR; GLUCOSE METABOLISM; GOLD STANDARD; HUMAN; IN VIVO STUDY; KIDNEY CANCER; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPHOMA; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MONOCYTE; PALATINE TONSIL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; SALIVARY GLAND CANCER; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; THYROID CANCER; TUMOR VOLUME; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; EPITOPES; FEMALE; GLUCOSE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TRANSKETOLASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84868525540     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.12.98     Document Type: Article

References (38)

1. Baum RP, Prasad V. Monitoring treatment. In: Clinical Nuclear Medicine. Cook GJR, Maisey MN, Britton KE, Chengazi V (Eds Hodder Arnold, London, UK, 57-78 (2006
2. Warburg OH, Posener K, Negelein E. On the metabolism of the cancer cell. Biochemistry 152, 309-344 (1924
3. Weber G. Enzymology of cancer cells. N. Engl. J. Med. 296, 541-551 (1977
4. Flier JS, Mueckler MM, Usher P, Lodish HF. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235(4795), 1492-1495 (1987 (Pubitemid 17038084)
5. Kelloff GJ, Hoffman JM, Johnson B et al. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin. Cancer Res. 11(8), 2785-2808 (2005 (Pubitemid 40525178)
6. von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: Current applications and future directions. Radiology 238(2), 405-422 (2006 (Pubitemid 43134354)
7. Baum RP, Swietaszczyk C, Prasad V. FDG-PET/CT in lung cancer: An update. Front. Radiat. Ther. Oncol. 42, 15-45 (2010
8. Hellwig D, Baum RP, Kirsch C. FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer: A systematic review. Nuklearmedizin 48(2), 59-69; quiz N8-N9 (2009
9. Lee JH, Rosen EL, Mankoff DA. The role of radiotracer imaging in the diagnosis and management of patients with breast cancer: Part 1 - overview, detection, and staging. J. Nucl. Med. 50(4), 569-581 (2009
10. Lee JH, Rosen EL, Mankoff DA. The role of radiotracer imaging in the diagnosis and management of patients with breast cancer: Part 2 - response to therapy, other indications, and future directions. J. Nucl. Med. 50(5), 738-748 (2009
11. Weiler-Sagie M, Bushelev O, Epelbaum R et al. (18)F-FDG avidity in lymphoma readdressed: A study of 766 patients. J. Nucl. Med. 51(1), 25-30 (2010
12. Fletcher JW, Djulbegovic B, Soares HP et al. Recommendations on the use of 18F-FDG PET in oncology. J. Nucl. Med. 49(3), 480-508 (2008 (Pubitemid 351355215)
13. Pfister DG, Johnson DH, Azzoli CG et al American society of clinical oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003 J. Clin. Oncol. 22(2), 330-353 (2004
14. Palaskas N, Larson SM, Schultz N et al. 18F-FDG PET marks MYC-overexpressing human basal like breast cancers. Cancer Res. 71(15), 5164-5174 (2011
15. Riganti C, Gazzano E, Polimeni M, Aldieri E, Ghigo D. The pentose phosphate pathway: An anti-oxidant defense and a cross-road in tumor cell fate. Free Radic. Biol. Med. 53(3), 421-436 (2012
16. Langbein S, Zerilli M, Zur Hausen A et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br. J. Cancer 94, 578-585 (2006 (Pubitemid 43289763)
17. Kohrenhagen N, Voelker HU, Schmidt M et al. Expression of transketolase-like 1 (TKTL1) and p-Akt correlates with the progression of cervical neoplasia. J. Obstet. Gynaecol. Res. 34, 293-300 (2008 (Pubitemid 351832337)
18. Zerilli M, Amato MC, Martorana A et al. Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases. Cancer 113, 936-944 (2008
19. Krockenberger M, Honig A, Rieger L et al. Transketolase-like 1 expression correlates with subtypes of ovarian cancer and the presence of distant metastases. Int. J. Gynecol. Cancer 17, 101-106 (2007 (Pubitemid 46213977)
20. Schmidt M, Voelker HU, Kapp M, Krockenberger M, Dietl J, Kammerer U. Glycolytic phenotype in breast cancer: Activation of Akt, upregulation of GLUT1, TKTL1 and down-regulation of M2PK. J. Cancer Res. Clin. Oncol. 136(2), 219-225 (2010
21. Schwaab J, Horisberger K, Strobel P et al. Expression of transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy. Biomed. Cancer 11, 363 (2011
22. Langbein S, Frederiks WM, zur Hausen A et al. Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer. Int. J. Cancer 122(11), 2422-2428 (2008 (Pubitemid 351590473)
23. Sun W, Liu Y, Glazer CA et al. TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1a stabilization. Clin. Cancer Res. 16(3), 857-866 (2010
24. Xu X, Zur Hausen A, Coy JF, Lochelt M. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells. Int. J. Cancer 124(6), 1330-1337 (2009
25. Hu LH, Yang JH, Zhang DT et al. The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells. Anticancer Drugs 18(4), 427-433 (2007
26. Kayser G, Sienel W, Kubitz B et al. Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression. Pathology 43(7), 719-724 (2011
27. Lange CA, Tisch-Rottensteiner J, Bohringer D, Martin G, Schwartzkopff J, Auw-Haedrich C. Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome. Ophthalmology 119(9), 1924-1929 (2012
28. Diaz-Moralli S, Tarrado-Castellarnau M, Alenda C, Castells A, Cascante M. Transketolase-like 1 expression is modulated during colorectal cancer progression and metastasis formation. PLoS ONE 6, e25323 (2011
29. Herwig R, Pelzer A, Horninger W et al. Measurement of intracellular versus extracellular prostate specific antigen levels in peripheral macrophages: A new approach to non-invasive diagnosis of prostate cancer. Clin. Prostate Cancer 3(3), 184-188 (2004 (Pubitemid 40051711)
30. Leers MP, Nap M, Herwig R, Delaere K, Nauwelaers F. Circulating PSA-containing macrophages as a possible target for the detection of prostate cancer. Am. J. Clin. Pathol. 129, 649-656 (2008
31. Japink D, Leers MP, Sosef MN, Nap M. CEA in activated macrophages. New diagnostic possibilities for tumor markers in early colorectal cancer. Anticancer Res. 29, 3245-3251 (2009
32. Boellaard R, O'Doherty MJ, Weber WA et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur. J. Nucl. Med. Mol. Imaging 37, 181-200 (2010
33. Prasad V, Baum RP. Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: Characterization of uptake in normal organs and tumor lesions. Q. J. Nucl. Med. Mol. Imaging 54, 61-67 (2010
34. Prasad V, Mehlhorn U, Feyen O, Coy J, Baum RP. Transketolase-like 1 (TKTL1), a new intracellular marker for staging of non-small cell lung cancer (NSCLC): Correlation with metabolic tumor volume on F-18 FDG PET/CT. J. Nucl. Med. 51(Suppl. 2), 1253 (2010
35. Hartmannsberger D, Mack B, Eggert C et al. Transketolase-like protein 1 confers resistance to serum withdrawal in vitro. Cancer Lett. 300, 20-29 (2011
36. Parihar A, Eubank TD, Doseff AL. Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death. J. Innate Immun. 2, 204-215 (2010
37. Tennant DA, Duran RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat. Rev. Cancer 10, 267-277 (2010
38. Furuta E, Okuda H, Kobayashi A, Watabe K. Metabolic genes in cancer: Their roles in tumor progression and clinical implications. Biochim. Biophys. Acta 1805, 141-152 (2010